TransCode Therapeutics Publishes Open Letter Outlining
An Open Letter to Shareholders of TransCode Therapeutics, Inc....
Stay updated with breaking news from Transcode Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An Open Letter to Shareholders of TransCode Therapeutics, Inc....
TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Free Report) was the target of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 437,500 shares, a decline of 31.3% from the November 30th total of 637,200 shares. Currently, 2.0% of the shares of the stock are […]
HC Wainwright reaffirmed their buy rating on shares of TransCode Therapeutics (NASDAQ:RNAZ – Free Report) in a report issued on Wednesday morning, Benzinga reports. HC Wainwright currently has a $3.00 target price on the stock. TransCode Therapeutics Stock Performance TransCode Therapeutics stock opened at $1.78 on Wednesday. TransCode Therapeutics has a 52-week low of $0.42 […]
HC Wainwright reiterated their buy rating on shares of TransCode Therapeutics (NASDAQ:RNAZ – Free Report) in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a $3.00 target price on the stock. TransCode Therapeutics Stock Performance NASDAQ:RNAZ opened at $1.78 on Wednesday. The firm has a market cap of $11.75 million, a […]